Equity Found: Cellino
Nov 26, 2021
Nabiha Saklayen, co-founder and CEO of Cellino, is revolutionizing access to cell therapies using innovative laser technology. She shares her journey from academia to entrepreneurship, highlighting her victory at TechCrunch Disrupt 2021. The conversation dives into building a skilled team, the significance of empathy in leadership, and the transformative impact of automated stem cell production on healthcare. Nabiha also emphasizes cultivating a positive workplace culture and the emotional motivations driving her quest for groundbreaking medical solutions.
AI Snips
Chapters
Transcript
Episode notes
Last-Minute Demo
- Nabiha Saklayen's team at Cellino built a live demo for TechCrunch Disrupt in just a few days.
- This showcased their automated stem cell production system, a feat Nabiha hadn't initially thought possible.
Democratizing Cell Therapy
- Cellino aims to democratize cell therapies by automating stem cell production.
- Their platform uses AI and lasers, dramatically lowering costs and increasing the yield of viable cells.
From Physics to Biotech
- Nabiha's journey to Cellino began with a personal loss, inspiring her to shift from theoretical physics to applied biology.
- Her work with lasers and stem cells at Harvard led to a surprising discovery, prompting others to encourage her startup.